Exploring the Efficacy of Repurposed Drugs in Treating COVID-19

This chapter delves into the underfunding of repurposed drugs for virus treatment, with a spotlight on fluvoxamine's successful trials. It discusses the promising outcomes of combining fluvoxamine with another drug, showcasing its low hospitalization rates and safety, hinting at their potential as an alternative to vaccines.